EMQs in Clinical Medicine.pdf - Peshawar Medical College
EMQs in Clinical Medicine.pdf - Peshawar Medical College
EMQs in Clinical Medicine.pdf - Peshawar Medical College
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
240 Miscellaneous<br />
When cyclophosphamide is broken down, its toxic metabolites (e.g.<br />
acrole<strong>in</strong>), which are irritant to the l<strong>in</strong><strong>in</strong>g of the ur<strong>in</strong>ary tract, give rise to<br />
a haemorrhagic cystitis. Mesna is a drug that is prescribed with<br />
cyclophosphamide to protect the uroepithelium. It acts by <strong>in</strong>hibit<strong>in</strong>g the<br />
decomposition of <strong>in</strong>termediate metabolites to acrole<strong>in</strong> and also b<strong>in</strong>ds<br />
directly with acrole<strong>in</strong> to prevent its toxic effect.<br />
A<br />
I<br />
A 25-year-old man on treatment for seizures compla<strong>in</strong>s of acne and<br />
gum hypertrophy.<br />
Acne, gum hypertrophy, nausea, vomit<strong>in</strong>g and tremor are all recognized<br />
adverse effects of phenyto<strong>in</strong> treatment. Blurred vision, ataxia or<br />
peripheral neuropathy are signs of drug toxicity. Phenyto<strong>in</strong> has a narrow<br />
therapeutic <strong>in</strong>dex and toxicity may easily occur.<br />
Adjustment of dose of phenyto<strong>in</strong> is complicated by the fact that it has zeroorder<br />
k<strong>in</strong>etics. This means that relatively small <strong>in</strong>creases <strong>in</strong> dose can give<br />
rise to large <strong>in</strong>creases <strong>in</strong> plasma concentration and consequently toxicity.<br />
A 24-year-old woman on treatment for epilepsy is admitted with<br />
acute pancreatitis.<br />
Acute pancreatitis is a rare adverse effect of valproate therapy but<br />
patients should be <strong>in</strong>formed of the symptoms and advised to seek<br />
immediate medical attention if these develop.<br />
95 Adverse drug reactions<br />
Answers: J L D H N<br />
J<br />
L<br />
A 32-year-old man on treatment for pulmonary TB presents with<br />
reduced sensation <strong>in</strong> a glove-and-stock<strong>in</strong>g distribution.<br />
Isoniazid is metabolized <strong>in</strong> the liver by acetylation. Toxicity <strong>in</strong> the form<br />
of peripheral neuropathy is more common <strong>in</strong> patients with a slow<br />
acetylator status, whereas fast acetylators are more likely to suffer from<br />
an isoniazid-related hepatitis. Rapid acetylator status is extremely common<br />
<strong>in</strong> the Japanese population (over 90 per cent). In the European population<br />
slow acetylator status is slightly more common (55–60 per cent).<br />
This is an example of a genetic polymorphism affect<strong>in</strong>g drug metabolism<br />
and toxicity.<br />
Sensitivity to ethanol and suxamethonium are other examples of variations<br />
<strong>in</strong> drug metabolism caused by genetic polymorphism.<br />
A 65 year old develops a photosensitive rash after be<strong>in</strong>g prescribed an<br />
additional drug for hypertension. Ant<strong>in</strong>uclear antibody test is positive.<br />
An SLE-like syndrome with a positive ant<strong>in</strong>uclear antibody test can be<br />
caused by a number of drugs, <strong>in</strong>clud<strong>in</strong>g hydralaz<strong>in</strong>e, proca<strong>in</strong>amide, isoniazid,<br />
griseofulv<strong>in</strong>, chlorpromaz<strong>in</strong>e and anticonvulsants. The symptoms<br />
usually disappear on removal of the drug.